The FDA has accepted Merck's (MRK) supplemental NDA with priority review for its drug Welireg for the treatment of a rare ...

Wall Street Journal's editorial board warned that Robert F. Kennedy Jr. is “dangerous to public health” and accused him of having deep conflicts of interest.

Robert F. Kennedy Jr. plans to continue earning from legal cases while heading the Department of Health and Human Services, ...

Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.

Pharma stocks have underperformed the market in the fourth quarter with the Stoxx Europe 600 Health Care index--which is heavily dominated by Europe's six largest pharma companies--down 9.4% against a ...

The first week of President Donald Trump’s second term included several executive orders and actions that will be detrimental ...

Robert F. Kennedy Jr. is set to appear before the Senate Finance Committee for the first of two confirmation hearings as ...

DeSantis’ refusal to accept over $320 million in federal funding for the Carbon Reduction Program (CRP) is alarming, ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Anti-RFK Jr. ads target GOP senatorsA ...

RFK Jr. faces unified opposition for HHS post; Trump disrupts NIH proceedings; Biogen CEO tells Mass. Gov there is “policy ...

Kennedy Jr. are battling over how aggressively to target vaccines during his first days as the nation’s health secretary, amid fears of a political backlash that could quickly swamp his agenda and ...